TRIAP1

TP53 regulated inhibitor of apoptosis 1 O43715 TRIA1_HUMAN
Protein Coding Chr 12 12q24.31 Swiss-Prot reviewed Entrez 51499
Mutations
33
CL 14 · Tissue 19
Samples
33
CL 14 · Tissue 19
Peptides
26
unique mutant peptides
Transcripts
1
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations331419
Samples331419
Peptides26918

Function

TRIAP1 · TP53 regulated inhibitor of apoptosis 1

Enables p53 binding activity. Contributes to phosphatidic acid transfer activity. Involved in several processes, including DNA damage response, signal transduction by p53 class mediator; negative regulation of apoptotic process; and positive regulation of phospholipid transport. Located in mitochondrial intermembrane space and nucleoplasm. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2022]

Isoforms & Proteins

1 transcript · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000546954 O43715 33 26

Gene Properties

Type
Protein Coding
Chromosome
12
Cytoband
12q24.31
Entrez ID
Aliases
HSPC132MDM35P53CSVWF-1

Recurrent Mutations

All 26 amino-acid changes on canonical ENST00000546954 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in TRIAP1 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in TRIAP1 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
Squamous Cell Lung Carcinoma
2/57 4%
1/810 0%
Ewings Sarcoma
1/63 2%
0/262 0%
Endometrial Carcinoma
1/42 2%
1/612 0%
Bladder Carcinoma
2/58 3%
1/956 0%
Colorectal Carcinoma
4/143 3%
3/3239 0%
Biliary Tract Carcinoma
0/54 0%
2/950 0%
Melanoma
0/210 0%
3/1899 0%
Esophageal Carcinoma
0/23 0%
1/769 0%
Non-Small Cell Lung Carcinoma
1/304 0%
1/1390 0%
Non-Cancerous
0/104 0%
1/830 0%
Neuroblastoma
1/87 1%
0/1331 0%
Head and Neck Carcinoma
0/85 0%
1/1574 0%
Pancreatic Carcinoma
0/89 0%
1/1611 0%
Breast Carcinoma
2/144 1%
0/3264 0%
Prostate Carcinoma
0/13 0%
1/2105 0%
Gastric Carcinoma
0/74 0%
1/1809 0%
Hepatocellular Carcinoma
0/46 0%
1/2210 0%

Mutation Distribution

Where TRIAP1 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in TRIAP1 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 54 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 33 mutations in TRIAP1

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide